Co-administration of diltiazem and cyclosporine for kidney transplant recipients: A four year follow-up study

Journal of the Medical Association of Thailand

Volumn 89, Issue SUPPL. 2, 2006, Pages

  Ingsathit, Atiporn ^a   Sumethkul, Vasant ^a   Chalermsanyakorn, Panas ^a   Jirasiritham, Sophon ^a  

^a MAHIDOL UNIVERSITY   (Thailand)

Author keywords

Chronic allograft nephropathy; Cyclosporine; Diltiazem; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CREATININE; CYCLOSPORIN A; DILTIAZEM; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE;

ADULT; ALLOGRAFT NEPHROPATHY; ARTICLE; BLOOD PRESSURE REGULATION; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DOSE RESPONSE; DRUG BLOOD LEVEL; FEMALE; FOLLOW UP; GRAFT REJECTION; GRAFT SURVIVAL; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; NEPHROTOXICITY; TREATMENT OUTCOME;

ABSORPTION; ADULT; AREA UNDER CURVE; BLOOD PRESSURE; CREATININE; CYCLOSPORINE; DILTIAZEM; DRUG ADMINISTRATION SCHEDULE; DRUG THERAPY, COMBINATION; EMULSIONS; FEMALE; FOLLOW-UP STUDIES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; MALE; POSTOPERATIVE PERIOD; VASODILATOR AGENTS;

EID: 33845463249     PISSN: 01252208     EISSN: 01252208     Source Type: Journal    
DOI: None     Document Type: Article

References (6)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D. Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000; 342: 605-12.
2. Kronbach T, Fischer V, Meyer UA. Cyclosporine metabolism in human liver: identification of a cytochrome P-450III gene family as the major cyclosporine-metabolizing enzyme explains interactions of cyclosporine with other drugs. Clin Pharmacol Ther 1988; 43: 630-5.
3. Weir MR. Therapeutic benefits of calcium channel blockers in cyclosporine-treated organ transplant recipients: blood pressure control and immunosuppression. Am J Med 1991; 90: 32S-6S.
4. Foradori A, Mezzano S, Videla C, Pefaur J, Elberg A. Modification of the pharmacokinetics of cyclosporine A and metabolites by the concomitant use of Neoral and diltiazem or ketoconazol in stable adult kidney transplants. Transplant Proc 1998; 30: 1685-7.
5. Palmer BF, Dawidson I, Sagalowsky A, Sandor Z, Lu CY. Improved outcome of cadaveric renal transplantation due to calcium channel blockers. Transplantation 1991; 52: 640-5.
6. Tredger JM, Roberts N, Sherwood R, Higgins G, Keating J. Comparison of five cyclosporin immunoassays with HPLC. Clin Chem Lab Med 2000; 38: 1205-7.